Home › NDC Lookup › RxCUI directory › RxCUI 261330

Carbidopa 25 MG Oral Tablet [Lodosyn] — RxCUI 261330

RxNorm drug concept · Semantic branded drug
RxCUI 261330 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI261330
Official nameCarbidopa 25 MG Oral Tablet [Lodosyn]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLodosyn 25 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Carbidopa: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Carbidopa makes levodopa work much better. Without it, most of the levodopa you swallow gets converted to dopamine in your body before it ever reaches your brain — causing nausea a...
  • Why do I need to take carbidopa? Can't I just take levodopa by itself?
  • The most common ones are involuntary movements — things like twisting, writhing, or jerking — as well as nausea, dizziness, and unusual drowsiness. Those involuntary movements can...
  • What side effects should I actually watch out for?
📖 Read our full Carbidopa guide →

🕸️ Concept Web — How Carbidopa 25 MG Oral Tablet [Lodosyn] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carbidopa 25 MG Oral Tablet [Lodosyn] RxCUI 261330

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Carbidopa 2019
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lodosyn 203437
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carbidopa Oral Tablet 374941
    • Carbidopa Oral Product 1156074
    • Carbidopa Pill 1156075
    • Carbidopa Oral Tablet [Lodosyn] 368213
    • Lodosyn Oral Product 1179620
    • Lodosyn Pill 1179621
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carbidopa 25 MG Oral Tablet SCD · 260260
  • Carbidopa 25 MG SCDC · 315568
  • Carbidopa Oral Tablet SCDF · 374941
  • Carbidopa Oral Product SCDG · 1156074
  • Carbidopa Pill SCDG · 1156075

Brand-Name Concepts

  • Carbidopa 25 MG [Lodosyn] SBDC · 574550
  • Carbidopa Oral Tablet [Lodosyn] SBDF · 368213
  • Lodosyn Oral Product SBDG · 1179620
  • Lodosyn Pill SBDG · 1179621
  • Lodosyn BN · 203437

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 261330 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
25010-0711-15 100 TABLET in 1 BOTTLE (25010-711-15) Lodosyn Bausch Health US, LLC 2010-04-13
Observed labelers: Bausch Health US, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.